Risk factors for the development and progression of hip osteoarthritis

Journal of Rheumatology

Volumn 32, Issue 6, 2005, Pages 1135-1136

  Hochberg, Marc C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2;

BODY MASS; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; FEMUR HEAD; HIP DISLOCATION; HIP DYSPLASIA; HUMAN; JOINT CAVITY; OSTEOARTHRITIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SPORT; TOTAL HIP PROSTHESIS; URINE LEVEL;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; EMPLOYMENT; HUMANS; OBESITY; OSTEOARTHRITIS, HIP; RISK FACTORS; SPORTS;

EID: 20444455386     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Lievense A, Bierma-Zeinstra S, Verhagen A, Verhaar J, Koes B. Influence of work on the development of osteoarthritis of the hip: a systematic review. J Rheumatol 2001;28:2520-8.
2. Lievense AM, Bierman-Zeinstra SM, Verhagen AP, van Baar ME, Verhaar JA, Koes BW. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology Oxford 2002;41:1155-62.
3. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, Bernsen RM, Verhaar JA, Koes BW. Influence of sporting activities on the development of osteoarthritis of the hip: a systematic review. Arthritis Care Res 2003;49:228-36.
4. Lievense AM, Bierma-Zeinstra SA, Verhagen AP, Verhaar JA, Koes BW. Influence of hip dysplasia on the development of osteoarthritis of the hip. Ann Rheum Dis 2004;63:621-6.
5. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, Verhaar JA, Koes BW. Prognostic factors of progress of hip osteoarthritis. A systematic review. Arthritis Care Res 2002;47:556-62.
6. Maillefert JF, Gueguen A, Monreal M, et al. Sex differences in hip osteoarthritis: results of a longitudinal study in 508 patients. Ann Rheum Dis 2003;62:931-4.
7. Altman RD, Bloch DA, Dougados M, et al. Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group. Osteoarthritis Cartilage 2004;12:515-24.
8. Maillefert JF, Gueguen A, Nguyen M, et al. Relevant change in radiological progression in patients with hip osteoarthritis: I. Determination using predictive validity for total hip arthroplasty. Rheumatology Oxford 2002;41:142-7.
9. Maillefert JF, Nguyen M, Gueguen A, et al. Relevant change in radiological progression inpatients with hip osteoarthritis: II. Determination using an expert opinion approach. Rheumatology Oxford 2002;41:148-52.
10. Dougados M, Gueguen A, Nguyen M, et al. Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status. Ann Rheum Dis 1996;55:356-62.
11. Abadie E, Ethgen D, Avouac B, et al. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis. Osteoarthritis Cartilage 2004;12:263-8.
12. Vignon E, Garnero P, Delmas P. et al. Respect of Ethics and Excellence in Science (GREES): Osteoarthritis Section. Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. Osteoarthritis Cartilage 2001;9:289-93.
13. Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas PD, Vignon E. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis 2003;62:939-43.
14. Mazieres B, for the ECHODIAH Investigators. Biological markers of osteoarthritis: data from the ECHODIAH cohort [French]. Presse Med 2004;33:S13-5.